Skip to main content
Erschienen in: Acta Neuropathologica 3/2007

01.09.2007 | Correspondence

More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains

verfasst von: Kurt A. Jellinger

Erschienen in: Acta Neuropathologica | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Excerpt

Multiple system atrophy (MSA), a largely sporadic adult-onset progressive synucleinopathy, is divided into two clinicopathologic subtypes: MSA-P [striatonigral degeneration (SND) with predominant Parkinsonian features] and MSA-C [olivopontocerebellar atrophy (OPCA) with predominant cerebellar ataxia], whereas autonomic dysfunction common to all forms of MSA and referred to previously as Shy-Drager syndrome (SDS), has been discouraged in the new consensus criteria [6]. Neuropathology, in addition to multisystem neurodegeneration involving the striatonigral and the ponto-cerebello-olivary systems in variable degrees and overlap [10], is hallmarked by α-synuclein positive glial cytoplasmic inclusions (GCI) mainly in oligodendroglia, the demonstration of which is required in the diagnosis of definite MSA and cause anatomically selective neuronal loss, gliosis, and myelin pathology [13]. Less frequent neuronal and astroglial cytoplasmic inclusions of similar composition, rare ubiquitin-positive neuronal nuclear or cytoplasmic inclusions resembling those in motoneuron disease, and ubiquitin-positive neuritic degeneration resembling neuropil threads but being tau-negative are seen in affected areas [13]. All these inclusions contain insoluble α-synuclein filaments [13], a subset of GCIs contains tau and 14-3-3 protein [5], which, together with other components, are also present in Lewy bodies (LB), the morphologic hallmarks of Parkinson disease (PD) and dementia with Lewy bodies (DLB) [12]. However, only a few reports have described the co-existence of GCIs and LBs (see [17, 18, 20, 26]). In the MSA cohort examined by Wenning et al. [26] with a mean age at death of 62.7 years the total prevalence of LBs was 20.3% (5/35 in substantia nigra and 3 in the neocortex), while Ozawa et al. [18] reported LBs in the brainstem in 7/94 cases (10.6%), but did not mention Alzheimer-related changes. …
Literatur
1.
Zurück zum Zitat Armstrong RA, Lantos PL, Cairns NJ (2007) Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinsonism Relat Disord 13:50–54PubMedCrossRef Armstrong RA, Lantos PL, Cairns NJ (2007) Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinsonism Relat Disord 13:50–54PubMedCrossRef
2.
Zurück zum Zitat Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239–259CrossRef Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239–259CrossRef
3.
Zurück zum Zitat Brown R (2007) Cognitive dysfunction in MSA (abstr.). In: Internatl. congr. on multiple system atrophy. Innsbruck, Austria, 12–13 January 2007 Brown R (2007) Cognitive dysfunction in MSA (abstr.). In: Internatl. congr. on multiple system atrophy. Innsbruck, Austria, 12–13 January 2007
4.
Zurück zum Zitat Burk K, Daum I, Rub U (2006) Cognitive function in multiple system atrophy of the cerebellar type. Mov Disord 21:772–776PubMedCrossRef Burk K, Daum I, Rub U (2006) Cognitive function in multiple system atrophy of the cerebellar type. Mov Disord 21:772–776PubMedCrossRef
5.
Zurück zum Zitat Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, Hurtig HI, Lee VM, Trojanowski JQ (2003) Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol (Berl) 106:243–250CrossRef Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, Hurtig HI, Lee VM, Trojanowski JQ (2003) Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol (Berl) 106:243–250CrossRef
6.
Zurück zum Zitat Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98PubMedCrossRef Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98PubMedCrossRef
7.
Zurück zum Zitat Jellinger KA (1998) Alzheimer-type lesions in Huntington’s disease. J Neural Transm 105:787–799PubMedCrossRef Jellinger KA (1998) Alzheimer-type lesions in Huntington’s disease. J Neural Transm 105:787–799PubMedCrossRef
8.
Zurück zum Zitat Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219–1235PubMedCrossRef Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219–1235PubMedCrossRef
9.
Zurück zum Zitat Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson’s disease. J Neural Transm 109:329–339PubMedCrossRef Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson’s disease. J Neural Transm 109:329–339PubMedCrossRef
10.
Zurück zum Zitat Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20(Suppl 12):S29–S36PubMedCrossRef Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20(Suppl 12):S29–S36PubMedCrossRef
11.
Zurück zum Zitat Josephs KA, Tsuboi Y, Cookson N, Watt H, Dickson DW (2004) Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol 61:1579–1584PubMedCrossRef Josephs KA, Tsuboi Y, Cookson N, Watt H, Dickson DW (2004) Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol 61:1579–1584PubMedCrossRef
12.
Zurück zum Zitat Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H (2002) 14-3-3 Proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 61:245–253PubMed Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H (2002) 14-3-3 Proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 61:245–253PubMed
13.
Zurück zum Zitat Lantos PL, Quinn N (2003) Dementia with Lewy bodies. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 188–199 Lantos PL, Quinn N (2003) Dementia with Lewy bodies. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 188–199
14.
Zurück zum Zitat Lindboe CF, Hansen HB (1998) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 17:204–209PubMed Lindboe CF, Hansen HB (1998) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 17:204–209PubMed
15.
Zurück zum Zitat Mikolaenko I, Pletnikova O, Kawas CH, O’Brien R, Resnick SM, Crain B, Troncoso JC (2005) Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore longitudinal study of aging (BLSA). J Neuropathol Exp Neurol 64:156–162PubMed Mikolaenko I, Pletnikova O, Kawas CH, O’Brien R, Resnick SM, Crain B, Troncoso JC (2005) Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore longitudinal study of aging (BLSA). J Neuropathol Exp Neurol 64:156–162PubMed
16.
Zurück zum Zitat Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed
17.
Zurück zum Zitat Mochizuki A, Komatsuzaki Y, Shoji S (2002) Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson’s disease. Acta Neuropathol (Berl) 104:534–537 Mochizuki A, Komatsuzaki Y, Shoji S (2002) Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson’s disease. Acta Neuropathol (Berl) 104:534–537
18.
Zurück zum Zitat Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657–2671PubMedCrossRef Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657–2671PubMedCrossRef
19.
Zurück zum Zitat Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57:82–91PubMedCrossRef Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57:82–91PubMedCrossRef
20.
Zurück zum Zitat Sikorska B, Papierz W, Preusser M, Liberski PP, Budka H (2007) Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies. Neuropathol Appl Neurobiol 33:126–129PubMed Sikorska B, Papierz W, Preusser M, Liberski PP, Budka H (2007) Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies. Neuropathol Appl Neurobiol 33:126–129PubMed
21.
Zurück zum Zitat Terni B, Rey MJ, Boluda S, Escribano BT, Sabate MP, Calopa M, van Leeuwen FW, Ferrer I (2007) Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Acta Neuropathol (Berl) 113:403–416CrossRef Terni B, Rey MJ, Boluda S, Escribano BT, Sabate MP, Calopa M, van Leeuwen FW, Ferrer I (2007) Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Acta Neuropathol (Berl) 113:403–416CrossRef
22.
Zurück zum Zitat Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (2006) Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 65:387–395PubMed Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (2006) Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 65:387–395PubMed
23.
Zurück zum Zitat Uchikado H, Delledonne A, Uitti R, Dickson DW (2006) Coexistence of PSP and MSA: a case report and review of the literature. Acta Neuropathol (Berl) 111:186–192CrossRef Uchikado H, Delledonne A, Uitti R, Dickson DW (2006) Coexistence of PSP and MSA: a case report and review of the literature. Acta Neuropathol (Berl) 111:186–192CrossRef
24.
Zurück zum Zitat Wenning GK, Jellinger KA (2005) The role of alpha-synuclein and tau in neurodegenerative movement disorders. Curr Opin Neurol 18:357–362PubMedCrossRef Wenning GK, Jellinger KA (2005) The role of alpha-synuclein and tau in neurodegenerative movement disorders. Curr Opin Neurol 18:357–362PubMedCrossRef
25.
Zurück zum Zitat Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58:160–166PubMedCrossRef Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58:160–166PubMedCrossRef
26.
Zurück zum Zitat Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12:133–147PubMedCrossRef Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12:133–147PubMedCrossRef
Metadaten
Titel
More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains
verfasst von
Kurt A. Jellinger
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 3/2007
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-007-0227-4

Weitere Artikel der Ausgabe 3/2007

Acta Neuropathologica 3/2007 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.